Laboratorijska dijagnoza Tracheobronhitisa psa čiji je uzročnik Bordatella bronchiseptica by Milanov, Dubravka et al.
Case report UDK 636.7:[616.233-002:616-07
LABORATORY DIAGNOSIS OF BORDATELLA 
BRONCHISEPTICA TRACHEOBRONCHITIS IN DOG
Dubravka Milanov1*, Milan Đilas2, Maja Velhner1, Nevenka Aleksić3
1 Scientific Veterinary Institute “Novi Sad“, Novi Sad, Serbia
2 Institute of Public Health of Vojvodina, Novi Sad, Serbia
3 Faculty of Veterinary Medicine, Belgrade, University of Belgrade, Serbia
Abstract
In the present paper the laboratory isolation and identification of Bor-
datella bronchiseptica, the causative agent of canine tracheobronhitis, is 
described. A dog which suffered persistent cough, loss of appetite and fever 
was previously unsucceffully treated with antibiotics, which is why nasal 
swabs were taken and sent for microbiological assessment. The isolation of 
the causative agent was performed on routinely used standard solid growth 
mediums. The final identification of the isolate was done with MALDI-TOF 
(matrix-assisted laser desorption/ionization - time of flight) and real-time 
PCR (polymerase chain reaction) assays. Therapy based on the results of 
the antibiogram lead to successful recovery. The necessity of cooperation 
of veterinary clinicians and veterinary microbiologists for timely and reli-
able identification of the microbe(s) and selection of antimicrobials based 
on the results of the susceptibility testing is emphasized. The significance 
of the collaboration between microbiological veterinary laboratories and 
those dealing with human material is underlined. These can provide precise 
identification of zoonotic agents.
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Kratak sadržaj
U ovom radu prikazujemo laboratorijsku izolaciju i identifikaciju Bor-
datella bronchiseptica, uzročnika traheobronhitisa psa. Pas koji je imao 
uporan kašalj, ispoljavao gubitak apetita i imao hipertermiju, prethodno 
je bez uspeha bio lečen antibioticima, zbog čega su brisevi nosa poslati 
na mikrobiološki pregled. Izolacija uzročnika izvedena je na podlogama 
koje se uobičajeno koriste u mikrobiološkim laboratorijama. Identifikacija 
izolata do vrste izvedena je primenom MALDI-TOF (matrix-assisted laser 
desorption/ionization - time of flight) i real-time PCR (polymerase chain 
reaction) metoda. Posle primene terapije na osnovu antibiograma, pas je 
uspešno izlečen. Istaknuta je neophodnost saradnje veterinara kliničara i 
veterinarskih mikrobioloških laboratorija u cilju blagovremene i pouzdane 
identifikacije uzročnika i odabira terapije na osnovu rezultata ispitivanja 
osetljivosti izolata na antibiotike. Dodatno ukazujemo na značaj poveza-
nosti mikrobioloških laboratorija humane i veterinarske medicine u pre-
ciznoj identifikaciji zoonotskih agenasa.
Ključne reči: Bordatella bronchiseptica, pas, traheobronhitis, MALDI 
TOF, real-time PCR
INTRODUCTION
Bacterial species of the Bordetella genus are inhabitants of the respirato-
ry system in both healthy and diseased animals and humans (Markey et al., 
2013). The most infamous among these is B. pertussis, the primary aetiologi-
cal agent of whooping cough, which can also be caused by B. parapertussis. A 
similar ailment in dogs is caused by B. bronchiseptica, and results in infectious 
tracheobronchitis, which may attack any dog breed at any age (Ford, 2006). 
In laymen it is referred to as kennel or canine cough and among profession-
als as canine croup. The etymology originates from the idea that it primarily 
affects dogs dwelling in kennels (but also other places where there are many 
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animals in limited areas), and that it resembles the synonymous childhood 
diseases. The pathogen is transmitted by direct contact or via Flügge drop-
lets (Vieson et al., 2012), but contaminated fomites may also serve as a source 
of infection (Datz, 2003). Following an incubation which lasts generally from 
two days to two weeks, the infected dogs start coughing; in the beginning the 
cough is a dry, paroxismal cough, but later transforms into productive, with 
nasal discharge, conjunctivitis and fever (Shelton et al., 1977). The most severe 
complications develop in young dogs due to the immaturity of their immune 
systems. Aged animals, those with impaired immunity and pregnant bitches 
are at higher risk. The disease may lead to tracheal collapse (Oskouizadeh et 
al., 2011). B. bronchiseptica has been identified in rabbits with bronchopneu-
monia, causing even septicaemia, in cats, horses, guinea pigs and rats suffer-
ing from respiratory ailments, and as an opportunistic agent contributing to 
atrophic rhinitis in pigs (Pittman, 1984; Datz, 2003). Although relatively rare 
in humans, it was found in people with endocarditis, peritonitis, meningitis 
and infected wounds, as well as in immunocompromised persons suffering 
from respiratory infections (Hadley et al., 2009; Woolfrey and Moody, 1991).
Several virulence factors play role in the pathogenesis of respiratory infec-
tions which develop owing to B. bronchisepica. For example, fimbriae (FIM), 
filamentous haemagglutinin (FHA) and pertactin (PTN) mediate the attach-
ment to specific receptors in the respiratory system (Datz, 2003). Since adhe-
sion is a prerequisite for invasion, flagella also may contribute to the adherence 
to eukaryotic cells (Savelkoul et al., 1996). B. bronchiseptica (and B. avium) 
are motile by peritrichous flagella (B. pertussis and B. parapertussis are non-
motile) (Markey et al., 2013). 
Not unlike other gram-negative bacteria, the outer membrane of Bordetella 
species contains a lipopolysaccharide endotoxin (Woolfrey and Moody, 1991). 
In addition, they produce several toxins: tracheal cytotoxin (TCT), dermon-
ecrotic toxin (DNT), osteotoxin, and adenylate cyclase toxin (ACT) (Markey 
et al., 2013). TCT disrupts ciliated cells (Cookson et al., 1989), DNT is capa-
ble of damaging tissues and suppresses both humoral and cellular immunity 
(Magyar et al., 2000), ACT inhibits the phagocytic function of neutrophils and 
macrophages (Datz, 2003) and ACT interferes with the activities of epithelial 
cells (Woolfrey and Moody, 1991). Pertussis toxin (PTX) is an exoprotein pro-
duced only by B. pertussis, although the corresponding genes are found also in 
B. parapertussis and B. bronchiseptica (Masin et al., 2015). 
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Isolation and identification of B. bronchiseptica.
From a four-month-old dog with symptoms of respiratory disease samples 
of nasal discharge were taken with two flexible nasal swabs. One sample was 
sent to the laboratory of the Scientific Veterinary Institute “Novi Sad” for the 
isolation of the microbes and the other was delivered to the Institute of Public 
Health of Vojvodina to be subjected to real time-PCR (polymerase chain reac-
tion) assay.
On arrival, the nasal swab was streaked on to Columbia blood agar base 
(CM0331, Oxoid, UK) with 5% defibrinated ovine blood and MacConkey agar 
(CM0007, Oxoid, UK). The plates were incubated at 37oC in aerobic condi-
tions. After 24h of incubation, the blood agar was covered in very small (0.5-1 
mm in diameter), convex, smooth, non-haemolytic colonies, which turned to 
opaque in the next 24h (Figure 1. A). On the MacConkey agar plate (Figure 1. 
B) the isolate gave rise to minute, pale colonies.
A. B.
Figure 1. Colonies of isolate on blood (A) and MacConkey agar (B) after 48h incuba-
tion at 37°C.
The isolate did not ferment carbohydrates (glucose, sucrose and arab-
inose), but was positive for catalase, urease and oxidase production, and cit-
rate utilization. When the slides were stained with Gram, small Gram-negative 
coccobacilli were revealed with light microscopy. Based on these characters, 
the isolate was identified as B. bronchiseptica, and was sent to the Institute of 
Public Health for confirmation by MALDI TOF (matrix-assisted laser desorp-
tion/ ionization - time of flight). 
The isolate was prepared using the standard Bruker’s direct transfer sample 
preparation procedure for MALDI-TOF MS. A single bacterial colony was spot-
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ted directly onto a MALDI target plate (Bruker Daltonics, Germany), allowed to 
dry and overlaid with 1.0 μL of matrix solution (Bruker Matrix HCCA; α-Cyano-
4-hydroxycinnamic acid). MALDI-TOF mass spectrometry was performed on 
Microflex LT/SH Biotyper system (Bruker Daltonics, Germany) under the con-
trol of flexControl software ver. 3.4 (Bruker Daltonics, Germany) (Fig 2). Spectra 
in the mass range of 2 to 20 kDa were collected by accumulating 240 laser shots 
(laser frequency, 60 Hz; ion source 1 voltage, 20 kV; ion source 2 voltage, 18.15 
kV; lens voltage, 6 kV) at 30–40% of maximum laser power. 
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Figure 2. Spectra of Bordatella bronchiseptica isolate generated by MALDI-TOF 
Bruker flexControl software.
RT-PCR. Bordetella species determination in the PCR with hybridization 
fluorescent detection includes three stages: DNA extraction from the sam-
ples, PCR amplification of pathogen genome specific region and real-time hy-
bridization fluorescent detection. In real-time PCR, the amplified product is 
detected with fluorescent dyes, linked to oligonucleotide probes which bind 
specifically to the amplified product during thermocycling. DNA was extract-
ed with the DNA-Sorb-A kit (Sacace, Italy). Real-time PCR was done with a 
commercial kit on SaCycler-96 system (Sacace, Italy). Bordetella pertussis /B. 
parapertussis/ B. bronchiseptica Real-TM PCR kit is an in vitro nucleic acid 
amplification test for detection and differentiation of these three species. It can 
be used for both clinical materials (nasal and oropharyngeal swabs) and mi-
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crobial cultures with real-time hybridization fluorescence detection. During 
the amplification stage, three simultaneous reactions take place – amplifica-
tion of the conservative region of ptxA gene that codes pertussistoxin located 
in B. pertussis, B. parapertussis and B. bronchiseptica genomes; identification 
of specific regions in genomes of B. pertussis and B. bronchiseptica, as well as 
amplification of nucleic acid sequence of the Internal Control (IC) sample. The 
target regions are detected by different detection channels (FAM for IC, JOE/
HEX for ptxA, ROX for B. pertussis and Cy5 for B. bronchiseptica). Sample was 
tested positive for B. bronchiseptica.
The susceptibility of B. bronchiseptica isolates to antibiotics was assessed 
with the standard disc-diffusion test on Müller-Hinton agar medium and pre-
sented in Table 1.
Table 1. Antibiotic susceptibility of B. bronchiseptica isolate 
Antibiotics (abbreviation & dose) Inhibition zone (mm)
Penicillin (P 10 U) 0
Amoxicillin (AX 25 mg) 0
Ampicillin (AM 10mg) 25
Amoxicillin/clavulanic acid (AMC 30mg) 30
Cefpodoxime (CPD 10mg) 0
Ceftazidime (CAZ 30mg) 32
Cefotaxime (CTX 30mg) 25
Ceftriaxone (CRO 30mg) 30
Erythromycin (E 15mg) 25
Tetracycline (TE 30 mg) 35
Streptomycin (S10 mg) 0
Trimethoprim/sulphamethoxazole (SXT 1.25/23.75 mg) 17
Neomycin (N 30mg) 12
Gentamicin (CN 10mg) 24
Enrofloxacin (ENR5mg) 28
Ciprofloxacin (CIP 5mg) 35
Nalidixic acid (NAL 30mg) 34
No breakpoints have been set for any of the antimicrobials tested for B. 
bronchiseptica susceptibility (Morrissey et al., 2016), which is why it is impos-
sible to catagorize the isolates even based on their MIC values (Kadlec et al., 
2006).
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COMMENT
Besides parainfluenza virus and canine adenovirus type 2, B. bronchisep-
tica is the most frequent causative agent of canine respiratory diseases (Datz, 
2003; Vieson et al., 2012). Although bordetella infection in the dog is usually 
mild and results in a self-limiting disease, it can be fatal for young animals. In 
this case, a four-month-old dog of mixed breed was treated empirically, with 
the combination of antibiotics: penicillin and streptomycin. Both were admin-
istered i.m., on five consecutive days: benzyl penicillin 20,000 IU/kg and strep-
tomycin 150 mg/kg. The laboratory testing was required due to the absence 
of the response to the therapy, but not before two weeks had passed from the 
onset of the symptoms. The results of in vitro investigation of the nasal swabs 
confirmed the clinical suspicion of antibiotic resistance, which is understand-
able. Streptomycin seems generally ineffective against B. bronchiseptica in vitro 
(Woolfrey and Moody, 1991). Despite the wide use of penicillin, ampicillin 
and amoxicillin for canine respiratory infections, they have been proven inef-
fective against B. bronchiseptica, except when the latter is combined with cla-
vulanate (Lappin et al., 2017). Resistance to penicillin has been reported in 
canine isolates (Markey et al., 2013). In addition, penicillin does not penetrate 
well into bronchial secretions, which impairs its efficacy. The susceptibility of 
B. bronchiseptica is intrinsically low to some β-lactams (e.g. penicillins and 
first-generation cephalosporines) owing to the production of β-lactamase and/
or low membrane permeability to cephalosporines (Prüller et al., 2015; Mor-
rissey et al., 2016). By contrast, aminoglycosides appear to be highly effective 
against B. bronchiseptica: in severe infections when animals do not respond 
to parenteral therapy, aerosolized gentamicin may be helpful (Vieson et al., 
2012). The most commonly used antibiotics are amoxicillin/clavulanic acid 
and cephalexin (Vieson et al., 2012). Tetracyclines are also highly efficacious 
in treating bordetellosis.
To conclude, antibiotics should be selected based on culture and sensitiv-
ity tests. Definitive diagnosis of B. bronchiseptica infection in dogs should be 
confirmed by microbiological findings in nasal or pharyngeal swabs. History 
and clinical signs can only imply that it is infectious tracheobronchitis caused 
by B. bronchiseptica we are dealing with. Frequently, it is necessary to cooper-
ate with public health diagnostic laboratories, which are provided with more 
sophisticated equipment and are capable of performing more precise diagnos-
tic procedures, as it was in this case. In addition, this collaboration can result 
in better insight into the epidemiology of zoonoses. The initiation of therapy 
should be guided by the clinical signs: in critically ill animals, empiric therapy 
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should start on the collection of swabs, but in those more stable, antimicro-
bial therapy should be postponed until the results of the antibiogram arrive, 
which takes two to three days. Treatment should last about two weeks, or seven 
days beyond the resolution of health problems (Leekha et al., 2011). When 
deciding on antibiotic therapy, veterinary surgeons must always have in mind 
the threatening possibility of resistance development and by giving adequate 
therapy not contribute to its emergence and spread.
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